The placenta in pre-eclampsia and intrauterine growth restriction

Journal of Clinical Pathology

Volumn 61, Issue 12, 2008, Pages 1254-1260

  Roberts, D J ^a   Post, M D ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; HISTOLOGY; HISTOPATHOLOGY; HUMAN; INTRAUTERINE GROWTH RETARDATION; PLACENTA; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; REVIEW;

DECIDUA; FEMALE; FETAL GROWTH RETARDATION; HUMANS; INFARCTION; PLACENTA; PRE-ECLAMPSIA; PREGNANCY;

EID: 57549083868     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2008.055236     Document Type: Review

References (65)

1. Bulletins ACoP. Intrauterine growth restriction. ACOG Practice Bulletin 2000;12:1-3.
2. Bulletins ACoP. Diagnosis and management of preecclampsia and eclampsia. Obstet Gynecol 2002;99:159-67.
3. Zhou Y, Damsky CH, Fisher SJ. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest 1997;99:2152-64.
4. Zhou Y, Fisher SJ, Janatpour M, et al. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J Clin Invest 1997;99:2139- 51.
5. Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003;111:649-58.
6. Venkatesha S, Toporsian M, Lam C, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006;12:642-9.
7. Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672-83.
8. Gensini GF, Conti AA. The evolution of the concept of 'fever' in the history of medicine: from pathological picture per se to clinical epiphenomenon land vice versa). J Infect 2004;49:85-97.
9. Salafia CM, Pezzullo JC, Ghidini A, et al. Clinical correlations of patterns of placental pathology in preterm pre-eclampsia. Placenta 1998;19:67-72.
10. Moldenhauer JS, Stanek J, Warshak C, et al. The frequency and severity of placental findings in women with preeclampsia are gestational age dependent. Am J Obstet Gynecol 2003;189:1173-7.
11. Kaplan CG. Fetal and maternal vascular lesions. Semin Diagn Pathol 2007;24:14-22.
12. Mayhew TM, Sampson C. Maternal diabetes mellitus is associated with altered deposition of fibrin-type fibrinoid at the villous surface in term placentae. Placenta 2003;24:524-31.
13. Bane AL, Gillan JE. Massive perivillous fibrinoid causing recurrent placental failure. BJOG 2003;110:292-5.
14. Ogishima D, Matsumoto T, Nakamura Y, et al. Placental pathology in systemic lupus erythematosus with antiphospholipid antibodies. Pathol Int 2000;50:224-9.
15. Sheppard BL, Bonnar J. Uteroplacental hemostasis in intrauterine fetal growth retardation. Semin Thromb Hemost 1999;25:443-6.
16. Kaufmann P, Huppertz B, Frank HG. The fibrinoids of the human placenta: origin, composition and functional relevance. Ann Anat 1996;178:485-501.
17. Ananth CV, Oyelese Y, Prasad V, et al. Evidence of placental abruption as a chronic process: associations with vaginal bleeding early in pregnancy and placental lesions. Eur J Obstet Gynecol Reprod Biol 2006;128:15-21.
18. Redline RW, Pappin A. Fetal thrombotic vasculopathy: the clinical significance of extensive avascular villi. Hum Pathol 1995;28:80-5.
19. Kraus FT. Placenta: thrombosis of fetal stem vessels with fetal thrombotic vasculopathy and chronic villitis. Pediatr Pathol Lab Med 1996;16:143-8.
20. Redline RW, Ariel I, Baergen RN, et al. Fetal vascular obstructive lesions: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol 2004;7:443-52.
21. Wilkins-Haug L, Roberts DJ, Morton CC. Confined placental mosaicism and intrauterine growth retardation: a case-control analysis of placentas at delivery. Am J Obstet Gynecol 1995;172:44-50.
22. Labarrere CA. Acute atherosis. A histopathological hallmark of immune aggression? Placenta 1988;9:95-108.
23. Perni SC, Predanic M, Cho JE, et al. Placental pathology and pregnancy outcomes in donor and non-donor oocyte in vitro fertilization pregnancies. J Perinat Med 2005;33:27-32.
24. Labarrere CA, Catoggio U, Mullen EG, et al. Placental lesions in maternal autoimmune diseases. Am J Reprod Immunol Microbiol 1986;12:78-86.
25. Redline R, Minich N, Taylor H, et al. Placental lesions as predictors of cerebral palsy and abnormal neurocognitive function at school age in extremely low birth weight infants (<1 kg). Pediatr Dev Pathol 2007;10:282-92.
26. Redline RW, Boyd T, Campbell V, et al. Maternal vascular underperfusion: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol 2004;7:237-49.
27. Sherer DM, Salafia CM. Chronic intrauterine bleeding and fetal growth at less than 32 weeks of gestation. Gynecol Obstet Invest 2000;50:92-5.
28. Naeye RL, Harkness WI, Utts J. Abruptio placentae and perinatal death: a prospective study. Am J Obstet Gynecol 1977;128:740-6.
29. Redline RW. Severe fetal placental vascular lesions in term infants with neurologic impairment. Am J Obstet Gynecol 2005;192:452-7.
30. Katz VL, Bowes WA Jr, Sierkh AE. Maternal floor infarction of the placenta associated with elevated second trimester serum alpha-fetoprotein. Am J Perinatol 1987;4:225-8.
31. Nickel RE. Maternal floor infarction: an unusual cause of intrauterine growth retardation. Am J Dis Child 1988;142:1270-1.
32. Sebire NJ, Backos M, El Gaddal S, et al. Placental pathology, antiphospholipid antibodies, and pregnancy outcome in recurrent miscarriage patients. Obstet Gynecol 2003;101:258-63.
33. Adams-Chapman I, Vaucher YE, Bejar RF, et al. Maternal floor infarction of the placenta: association with central nervous system injury and adverse neurodevelopmental outcome. J Perinatol 2002;22:236- 41.
34. Katzman PJ, Genest DR. Maternal floor infarction and massive perivillous fibrin deposition: histological definitions, association with intrauterine fetal growth restriction, and risk of recurrence. Pediatr Dev Pathol 2002;5:159-64.
35. Sebire NJ, Backos M, Goldin RD, et al. Placental massive perivillous fibrin deposition associated with antiphospholipid antibody syndrome. BJOG 2002;109:570-3.
36. Katz VL, DiTomasso J, Farmer R, et al. Activated protein C resistance associated with maternal floor infarction treated with low-molecular-weight heparin. Am J Perinatol 2002;19:273-7.
37. Raspollini MR, Oliva E, Roberts DJ. Placental histopathologic features in patients with thrombophilic mutations. J Mater Fetal Neonatal Med 2007;20:113-23.
38. Matern D, Schehata BM, Shekhawa P, et al. Placental floor infarction complicating the pregnancy of a fetus with long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency. Mol Genet Metab 2001;72:265-8.
39. Bendon RW, Hommel AB. Maternal floor infarction in autoimmune disease: two cases. Pediatr Pathol Lab Med 1996;16:293-7.
40. Doss BJ, Greene MF, Hill J, et al. Massive chronic intervillositis associated with recurrent abortions. Hum Pathol 1995;26:1245-51.
41. Boyd TK, Redline RW. Chronic histiocytic intervillositis: a placental lesion associated with recurrent reproductive loss. Hum Pathol 2000;31:1389-96.
42. Jacques SM, Qureshi F. Chronic intervillositis of the placenta. Arch Pathol Lab Med 1993;117:1032-5.
43. Labarrere C, Mullen E. Fibrinoid and trophoblastic necrosis with massive chronic intervillositis: an extreme variant of villitis of unknown etiology. Am J Reprod Immunol Microbiol 1987;15:85-91.
44. Weber MA, Nikkels PG, Hamoen K, et al. Co-occurrence of massive perivillous fibrin deposition and chronic intervillositis: case report. Pediatr Dev Pathol 2006;9:234-8.
45. Bong G. Chronic villitis of unknown etiology. Eur J Obstet Gynecol Reprod Biol 2008;136:9-15.
46. Redline RW. Villitis of unknown etiology: noninfectious chronic villitis in the placenta. Hum Pathol 2007;38:1439-46.
47. Benirschke K, Coen R, Patterson B, et al. Villitis of known origin: varicella and toxoplasma. Placenta 1999;20:395-9.
48. Kraus FT, Acheen VI. Fetal thrombotic vasculopathy in the placenta: cerebral thrombi and infarcts, coagulopathies, and cerebral palsy. Hum Pathol 1999;30:759-69.
49. Kraus FT. Placental thrombi and related problems. Semin Diagn Pathol 1993;10:275-83.
50. Altemani AM, Sarian MZ. Hemorrhagic endovasculitis of the placenta. A clinical-pathological study in Brazil. J Perinat Med 1995;23:359-63.
51. Sander CM. Hemorrhagic endovasculitis of the placenta. Am J Obstet Gynecol 1992;167:1483.
52. Shen-Schwarz S, Macpherson TA, Mueller-Heubach E. The clinical significance of hemorrhagic endovasculitis of the placenta. Am J Obstet Gynecol 1988;159:48-51.
53. Sander CH. Hemorrhagic endovasculitis and hemorrhagic villitis of the placenta. Arch Pathol Lab Med 1980;104:371-3.
54. Sienko A, Ahshuler G. Meconium-induced umbilical vascular necrosis in abortuses and fetuses: a histopathologic study for cytokines. Obstet Gynecol 1999;94:415-20.
55. Altshuler G, Arizawa M, Molnar-Nadasdy G. Meconium-induced umbilical cord vascular necrosis and ulceration: a potential link between the placenta and poor pregnancy outcome. Obstet Gynecol 1992;79:760-6.
56. Altshuler G, Hyde S. Meconium-induced vasocontraction: a potential cause of cerebral and other fetal hypoperfusion and of poor pregnancy outcome. J Child Neurol 1989;4:137-42.
57. Vern TZ, Alles AJ, Kowal-Vern A, et al. Frequency of factor V (Leiden) and prothrombin G20210A in placentas and their relationship with placental lesions. Hum Pathol 2000;31:1036-43.
58. Roberts DJ, Ampola MG, Lage JM. Diagnosis of unsuspected fetal metabolic storage disease by routine placental examination. Pediatr Pathol 1991;11:647-56.
59. Pinar H, Sung CJ, Oyer CE, et al. Reference values for singleton and twin placental weights. Pediatr Pathol Lab Med 1996;16:901-7.
60. Ogino S, Redline RW. Villous capillary lesions of the placenta: distinctions between chorangioma, chorangiomatosis, and chorangiosis. Hum Pathol 2000;31:945-54.
61. Schwartz DA. Chorangiosis and its precursors: underdiagnosed placental indicators of chronic fetal hypoxia. Obstet Gynecol Surv 2001;56:523-5.
62. Altshuler G. Chorangiosis. An important placental sign of neonatal morbidity and mortality. Arch Pathol Lab Med 1984;108:71-4.
63. Hladunewich M, Karumanchi SA, Lafayette R. Pathophysiology of the clinical manifestations of preeclampsia. Clin J Am Soc Nephrol 2007;2:543-9.
64. Mutter WP, Karumanchi SA. Molecular mechanisms of preeclampsia. Microvasc Res 2008;75:1-8.
65. Widmer M, Villar J. Benign A, et al. Mapping the theories of preeclampsia and the rose of angiogenic factors: a systematic review. Obstet Gynecol 2007;109:168-80.